Altered Mental Status in Cancer.

Jorg Dietrich, John Y Rhee, Vihang Nakhate, Christy Soares, Zachary Tentor

Journal: Seminars in neurology 2024;44(6):652-669

PMID: 39102863

Abstract

Patients with cancer experience high rates of alterations in mental status. The mechanisms for altered mental status (AMS) in this population are manifold. The cancer itself may cause AMS through direct invasion of the central nervous system or as metastatic leptomeningeal spread. However, cancer patients are also vulnerable to tumor-associated complications such as seizures, cerebral edema, strokes, or cancer treatment-related complications such as infections, direct neural injury from radiation or chemotherapy, edema, or dysregulated autoimmune response from immunotherapies. Both during treatment and as sequelae, patients may suffer neurocognitive complications from chemotherapy and radiation, medications or opportunistic infections, as well as toxic-metabolic, nutritional, and endocrine complications. In this review, we describe a clinical approach to the cancer patient presenting with AMS and discuss the differential drivers of AMS in this patient population. While common etiologies of AMS in noncancer patients (toxic-metabolic or infectious encephalopathy, delirium) are also applicable to cancer patients, we additionally provide a cancer-specific differential diagnosis that warrants special consideration in the cancer patient with AMS.

Thieme. All rights reserved.

Address: Division of Neuro-Oncology, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.; Division of Adult Palliative Care, Department of Psychosocial Oncology and Palliative Care, Dana Farber Cancer Institute, Boston, Massachusetts.; Department of Neurology, Harvard Medical School, Boston, Massachusetts.; Division of Neuro-Oncology, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.; Department of Neurology, Harvard Medical School, Boston, Massachusetts.; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts.; Department of Neurology, Emory University School of Medicine, Atlanta, Georgia.; Division of Adult Palliative Care, Department of Psychosocial Oncology and Palliative Care, Dana Farber Cancer Institute, Boston, Massachusetts.; Department of Neurology, Harvard Medical School, Boston, Massachusetts.; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.